CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Outcomes of Third-Line Docetaxel-Based Chemotherapy in Advanced Gastric Cancer Who Failed Previous Oxaliplatin-Based and Irinotecan-Based Chemotherapies

Min Jeong Lee, In Gyu Hwang, Joung-Soon Jang, Jin Hwa Choi, Byeong-Bae Park, Myung Hee Chang, Seung Tae Kim, Se Hoon Park, Myoung Hee Kang, Jung Hun Kang

Cancer Research and Treatment. 2012;44(4):235-241. Published online 2012 December 31 DOI: https://doi.org/10.4143/crt.2012.44.4.235

Third-Line Weekly Docetaxel Chemotherapy in Advanced Gastric Cancer Who Failed Previous Fluoropyrimidine and Irinotecan or Oxaliplatin-Based Chemotherapies

G.J. Lee, Y.S. Hong, S.Y. Roh

Annals of Oncology. 2014;25:iv230

Link1 Link2 Link3

Outcomes of Third-Line Docetaxel-Based Chemotherapy in Advanced Gastric Cancer Who Failed Previous Oxaliplatin-Based and Irinotecan-Based Chemotherapies

Min Jeong Lee, In Gyu Hwang, Joung-Soon Jang, Jin Hwa Choi, Byeong-Bae Park, Myung Hee Chang, Seung Tae Kim, Se Hoon Park, Myoung Hee Kang, Jung Hun Kang

Cancer Research and Treatment. 2012;44(4):235-241

Link1

Link2

P-0039 Irinotecan as a Second/Third Line Chemotherapy in Gastric Cancer Patients who Failed S-1-Based Treatment

Yasuhiro Kodera, Norifumi Ohashi, Yoshinari Mochizuki, Kiyoshi Ishigure, Chie Tanaka, Suguru Yamada, Daisuke Kobayashi, Tsutomu Fujii, Michitaka Fujiwara, Seiji Ito

Annals of Oncology. 2012;23:iv42

Link1 Link2

Irinotecan Monotherapy Versus Irinotecan-Based Combination as Second-Line Chemotherapy in Advanced Gastric Cancer: A Meta-Analysis

Yo-Han Cho, So Young Yoon, Soo-Nyung Kim

Cancer Research and Treatment. 2017;49(1):255-262

Link1

Link2 Link3

Docetaxel-based chemotherapy as second-line regimen for advanced thymic carcinoma

Zhengbo Song, Xinmin Yu, Chunxiao He, Beibei Zhang, Yiping Zhang

Thoracic Cancer. 2014;5(2):169-173

Link1 Link2

POSA168 Meta-Analysis and Cost-Effectiveness Analysis of Oxaliplatin-Based Chemotherapy Versus Irinotecan-Based Chemotherapy for the First-Line Treatment of Metastatic Advanced Colorectal Cancer in China

X Zhang, W Su, Z Lin, Y Jian, J Xuan

Value in Health. 2022;25(1):S66-S67

Link1 Link2

O-4 A randomized phase II study of docetaxel versus docetaxel and irinotecan in patients with stage IIIb-IV non-small-cell lung cancer who failed first line chemotherapy

H.J.M. Groen, F.M. Wachters, B. Biesma, F.M.N.H. Schramel, J.A. Stigt, E.F. Smit

Lung Cancer. 2003;41:S5

Link1 Link2

POSC167 A Meta-Analysis and Cost-Minimization Analysis of Oxaliplatin-Based Chemotherapy Versus Irinotecan-Based Chemotherapy with Targeted Molecular Agents in the First-Line Treatment of Metastatic Advanced Colorectal Cancer in China

X Zhang, W Su, Z Lin, T Bao, Y Jian, J Xuan

Value in Health. 2022;25(1):S120

Link1 Link2

A Randomized Trial of Different Docetaxel Schedules in Non-small Cell Lung Cancer Patients Who Failed Previous Platinum-Based Chemotherapy

Yuh-Min Chen, Jen-Fu Shih, Reury-Perng Perng, Chun-Ming Tsai, Jacqueline Whang-Peng

Chest. 2006;129(4):1031-1038

Link1 Link2

Salvage S-1 monotherapy in metastatic colorectal cancer patients who failed irinotecan-based or oxaliplatin-based chemotherapy

Duk Joo Lee, Jeeyun Lee, Ha Yeon Lee, Taekyu Lim, Su Jin Lee, Seong Yoon Yi, Se Hoon Park, Joon Oh Park, Ho Yeong Lim, Won Ki Kang, Young Suk Park

Medical Oncology. 2010;28(S1):291-294

Link1

Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.